Vivani Medical (STU:U5P) ROE % Adjusted to Book Value: -23.05% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:U5P Vivani Medical Inc STU:U5P
35 GF Score
Price €1.17
! 1 Warning Sign
View Full Analysis

What is Vivani Medical ROE % Adjusted to Book Value?

Vivani Medical STU:U5P -6.40% 35 ROE % Adjusted to Book Value is -23.05% as of Jun. 2026. GuruFocus rates STU:U5P with a GF Score™ of 35/100. The stock has 1 warning sign investors should review.

Vivani Medical's ROE % for the quarter that ended in Jun. 2026 was -134.15%. Vivani Medical's PB Ratio for the quarter that ended in Jun. 2026 was 5.82. Vivani Medical's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2026 was -23.05%.

Vivani Medical ROE % Adjusted to Book Value Related Terms

Vivani Medical ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Vivani Medical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivani Medical ROE % Adjusted to Book Value Chart

Vivani Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial 0.00 -62.72 -30.67 -32.58 -25.90

Vivani Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.61 -12.86 -53.71 -35.29 -23.05

STU:U5P vs BDTX, VTVT, TLSA: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Vivani Medical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vivani Medical ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vivani Medical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Vivani Medical's ROE % Adjusted to Book Value falls into.


STU:U5P
35GF Score
Vivani Medical Inc STU:U5P
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivani Medical ROE % Adjusted to Book Value Calculation

Vivani Medical's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-150.24% / 5.80
=-25.90%

Vivani Medical's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-134.15% / 5.82
=-23.05%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -23.05% mean?
Vivani Medical (STU:U5P) has a ROE % Adjusted to Book Value of -23.05% as of Jun. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Vivani Medical and its competitors.
Is Vivani Medical's ROE % Adjusted to Book Value too high?
Vivani Medical's current ROE % Adjusted to Book Value is -23.05%. Overall, Vivani Medical has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Vivani Medical's ROE % Adjusted to Book Value compare to BDTX and VTVT?
Vivani Medical's ROE % Adjusted to Book Value of -23.05% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Vivani Medical and its competitors. Vivani Medical's current ROE % Adjusted to Book Value is -23.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivani Medical stock overvalued right now?
Vivani Medical (STU:U5P) has a current ROE % Adjusted to Book Value of -23.05%. The current ROE % Adjusted to Book Value is -23.05%. Vivani Medical's overall GF Score™ is 35/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Vivani Medical (STU:U5P), the current ROE % Adjusted to Book Value is -23.05% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vivani Medical Business Description

Other Exchanges VANI:USA
Address 1350 South Loop Road, Alameda, CA, USA, 94502
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
35GF Score

Get the complete analysis for STU:U5P

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.17
Price